CPTIC: A Potential Drug Target for Neurological Disorders (G126129)

Target Name: CPT1C

NCBI ID: G126129

CPTIC: A Potential Drug Target for Neurological Disorders

CPT1C, also known as CPTIC, is a protein that is expressed in the brain and is involved in the regulation of cell survival and proliferation. The CPTIC protein has been identified as a potential drug target for the treatment of various neurological disorders, including Alzheimer's disease , Parkinson's disease, and multiple sclerosis.

CPTIC was first identified in the 1990s as a protein that was expressed in the brain and was involved in the regulation of cell survival and proliferation. Since then, research has continued to investigate the role of CPTIC in the development and progression of neurological disorders.

One of the key functions of CPTIC is its role in the regulation of cell survival. CPTIC has been shown to play a role in the regulation of cell survival by promoting the production of cell survival signals, such as the neurotrophic factor (NTF), which promotes the survival and proliferation of neurons.

CPTIC has also been shown to play a role in the regulation of cell proliferation. Studies have shown that CPTIC can promote the production of new neurons and can also inhibit the production of neurons that are no longer needed. This regulation of cell proliferation is critical for the development and maintenance of the nervous system.

In addition to its role in cell survival and proliferation, CPTIC has also been shown to play a role in the regulation of neural plasticity. Neural plasticity is the ability of the brain to change and adapt over time in response to experience and environmental changes. Studies have shown that CPTIC can regulate the growth and connectivity of neural fibers, which are responsible for transmitting electrical signals throughout the brain.

The potential drug target for CPTIC is based on its involvement in the regulation of cell survival and proliferation. Studies have shown that CPTIC can be expressed in the brain and that it is involved in the regulation of cell survival and proliferation. This suggests that CPTIC may be a useful drug target for the treatment of neurological disorders.

One of the challenges in developing a drug target for CPTIC is its location in the brain. CPTIC is expressed in the brain, but its exact location and the mechanisms by which it is involved in the regulation of cell survival and proliferation are not well understood. Further research is needed to determine the exact mechanisms by which CPTIC is involved in the regulation of cell survival and proliferation.

Another challenge is the development of a reliable and effective drug that can specifically target CPTIC. Currently, there are no FDA-approved drugs that specifically target CPTIC. Researchers are working to develop new drugs that can specifically target CPTIC and are investigating the potential clinical applications of these drugs.

In conclusion, CPTIC is a protein that is expressed in the brain and is involved in the regulation of cell survival and proliferation. Its potential as a drug target for the treatment of neurological disorders is based on its involvement in the regulation of cell survival and proliferation. . Further research is needed to understand the exact mechanisms by which CPTIC is involved in the regulation of cell survival and proliferation and to develop reliable and effective drugs that can specifically target CPTIC.

Protein Name: Carnitine Palmitoyltransferase 1C

Functions: May play a role in lipid metabolic process

More Common Targets